Search Results
Results found for "Lauren T May"
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
Lauren M. Slosky About Dr. Lauren M. Slosky Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member of the they are exciting tools for linking distinct signaling pathways with their physiological effects and may Lauren M.
- Lauren Solano: Mapping Careers Beyond the Bench | Dr. GPCR Ecosystem
Career coach Lauren Solano on the skills PhDs undersell, the careers they don't know exist, and the introspection exercise that maps functions to scientific training. << Back to podcast list Strategic Partner(s) Lauren Lauren Solano, CEO and co-founder of Propel Careers, has spent more than a decade coaching PhDs and postdocs About the Guest Lauren Solano is CEO and co-founder of Propel Careers, a Boston-based firm that coaches Lauren Celano on the web LinkedIn Propel Careers Email: Lauren@propelcareers.com Dr.
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
Lauren Slosky About Irfan Dhanidina "My interest in oncology research led me to pursue a BSc in Biology Lauren Slosky "Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member they are exciting tools for linking distinct signaling pathways with their physiological effects and may Lauren Slosky on the web University of Minnesota Department Page Twitter LinkedIn Google Scholar PubMed
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
Lauren Sloksy (2020) Dr. Josh C Snyder (2012) Dr.
- Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem
Richard Vile's lab at Mayo Clinic where she aided the evaluation of tumor-specific oncolytic viruses. Lauren Slosky, she is working to understand the mechanism by which a new class of biased allosteric modulators
- Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem
Lauren Slosky and Dr. Joshua Gross were enthusiastic about the idea and jumped on board.
- Dr. Mark Connor | Dr. GPCR Ecosystem
McCleskey, sensory neuron properties); Pain Management Research Institute (more opioids, cannabinoids and T-type
- Dr. Stephane Angers | Dr. GPCR Ecosystem
Randall T.
- Trademark Policy | Dr. GPCR Ecosystem
Buttons And Badges Policy Publishers may not attempt to discover the identity of a Dr. Publishers may not alter or obfuscate a Dr. GPCR button, and Publishers may not associate a Dr. For the avoidance of doubt, Publishers may direct users to a Dr. FindYooour may analyze Publishers' use of a Dr. GPCR Logo in different marketing materials, such as a new T-shirt design, a toy, software packaging,
- Chris Langmead | Dr. GPCR Ecosystem
Christopher Langmead on the web Monash University T witter Google Scholar Linkedin PubMed Monash Neuromedicines
- Content Guidelines | Dr. GPCR Ecosystem
We rely heavily on users to report content that may violate our policies. Beyond the guidelines listed below, please note that several products and features may have additional You may not imply that Your Content is in any way sponsored or endorsed by Ecosystem.DrGPCR.com. For example, we may remove a review if we believe it violates our Content Guidelines. In emergency situations, we may escalate imminent threats of serious harm to law enforcement.
- Content and Conduct Policy | Dr. GPCR Ecosystem
We rely heavily on users to report content that may violate our policies. Beyond the guidelines listed below, please note that several products and features may have additional You may not imply that Your Content is in any way sponsored or endorsed by Ecosystem.DrGPCR.com. For example, we may remove a review if we believe it violates our Content Guidelines. In emergency situations, we may escalate imminent threats of serious harm to law enforcement.
- Affiliate Policy | Dr. GPCR Ecosystem
Affiliates may leave the Affiliate Program and terminate this agreement at any time by sending an email Participation in the Affiliate Program may be limited to affiliates located in certain countries and Commission rates are determined on a case-by-case basis and may vary based on various factors such as Commissions may increase during limited-time special promotions. GPCR websites and may not receive any commissions. Paid Search Dr.
- Dr. GPCR Board | Dr. GPCR Ecosystem
Maria Waldhoer on the web LinkedIn T witter Pubmed Dr. GPCR About Dr. JoAnn Trejo "Dr.
- Our History | Dr. GPCR Ecosystem
May 2022 — Episode #42 released featuring Dr. Randy Hall , Emory University. May 2022 — Media Partner at GPCR Retreat . Jul 2022 — Media Partner at GPCR ECI Transatlantic . First Symposium May 19, 2023 — Hosted the inaugural Dr. Podcast Milestones May 9, 2024 — Episode #150 introduced the Dr. GPCR Team . May 16, 2024 — Episode #151 featured the Dr. GPCR Board .
- Terms and Conditions | Dr. GPCR Ecosystem
do not have such authority, or if you do not agree with this ATS, you must not accept this ATS and may GPCR”) may change this ATS from time to time without prior notice. Customer understands that the operation of the Services, including Customer Information, may involve THIRD PARTIES: The Services may provide links or other access to other websites, and resources on the ASSIGNMENT: Customer may not assign this ATS without the written consent of Ecosystem.DrGPCR.com.
- Privacy Policy | Dr. GPCR Ecosystem
Where required, this information may include your personal contact information and/or your company contact Ecosystem.DrGPCR.com may use this information to customize the advertising and content you see and to Information Sharing and Disclosure Ecosystem.DrGPCR.com may disclose your personal information to third Ecosystem.DrGPCR.com may otherwise disclose your personal information when: We have your express consent Changes to this Privacy Policy Ecosystem.DrGPCR.com may, at any time, without notice to you and, in its
- Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem
2025 | American Physiology Summit 2025 - USA April 25 - 30, 2025 | AACR Annual Meeting 2025 - USA NEW May 1 - 2, 2025 | 5th Ace Drug Discovery Summit 2025 - USA NEW May 12 - 15, 2025 | ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025 - USA May 12 - 15, 2025 | PEGS 2025 - USA May 15 - 17, 2025 | 23rd GPCR Retreat 2025 - USA May 20 - 22, 2025 | SLAS Europe 2025 - Germany May 20 - 22, 2025 |4th GPCRs-Targeted Drug
- FAQ | Dr. GPCR Ecosystem
Selected recordings may be available afterward through the Dr. GPCR platform. While some sessions may introduce key concepts, the overall level is advanced and assumes familiarity Topics may include: Receptor efficacy and operational models Allosteric modulators (PAMs and NAMs) Biased
- Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
Amynah Pradhan on why mu opioids worsen migraine, why delta agonists may relieve it, and how chronic scientific focus for nearly two decades, through failed clinical trials in depression and pain, and migraine may Delta agonists may finally have a disease. After failed trials in depression and pain, Dr. comorbidity, its anatomical overlap with delta receptor expression, and its distinctive pain mechanisms — may hype cooled 34:08 How you measure migraine in a mouse 40:44 Three aha moments — and why delta agonists may
- Your GPCR Order Has Arrived! ❇ Feb 10 - 16, 2025 | Dr. GPCR Ecosystem
✅ Practical Quantification of Allosteric Modulation – May 1, 2025 ✅ Applying the Black/Leff Operational April 24 - 27, 2025 | American Physiology Summit 2025 April 25 - 30, 2025 | AACR Annual Meeting 2025 May 12 - 15, 2025 | PEGS 2025 May 15 - 17, 2025 | 23rd GPCR Retreat 2025 May 20 - 22, 2025 | SLAS Europe 2025 NEW May 20 - 22, 2025 |4th GPCRs-Targeted Drug Discovery Summit June 22 - 26, 2025 | G Protein-coupled
- Join the Dr. GPCR Affiliate Program - Empower the GPCR Community with Dr. GPCR Ecosystem Services
GPCR may also remove affiliates from the program at any time. Yes, you may join the affiliate program as long as you have a verified PayPal account. Please note that we may withhold awards where we believe customers are acting in bad faith or otherwise
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
on G protein hotspot mutations, why the canonical GαQ pathway fails in uveal melanoma, and how CXCR3 may believed in to a recognized driver class in oncology, and explains why chemokine receptors like CXCR3 may CXCR3 may be the hidden gatekeeper of immunotherapy response. no one believed in 10:52 The cancer genomics result that reframed GPCRs as drivers 16:45 Why CXCR3 may
- Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem
A single-target drug may be the wrong goal for complex disease. For schizophrenia and other neuropsychiatric conditions, the genetic landscape may simply be too complex scientists who don't have ten Nature papers Timestamps were generated using AI for readability and may And that just may be the wrong hypothesis. It typically is the wrong hypothesis."
- Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem
work focuses on wild-type receptors, while patients with genetic disease are born with receptors that may behave very differently - and that may respond differently to existing drugs. EPISODE TIMELINE Timestamps are AI-generated approximations based on transcript markers and may not reflect "Ligands that display biased signaling property may serve as highly specific drug candidates. their interests and to work on projects that they're passionate about and not simply projects that may
- Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
how unbiased GPCR expression profiling uncovered overlooked receptors in cancer — and why the field may cancer-associated fibroblasts, creating feedback loops between the tumor microenvironment and stroma that may This challenges the mutation-centric framework that dominates oncology and suggests GPCRs may contribute The field's reductionism may be hiding how receptors actually work Dr.
- Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem
GPCRs, RAMPs, and the selectivity problem in CGRP-targeted migraine therapies - what the approved drugs may two receptor complexes, combined with the known pharmacology of CGRP at CTR-RAMP1, suggest the drug may be less target-selective than its approval label implies - and that effects attributed to one target may Minor offsets may occur in the final edited episode. 00:00 Welcome and episode announcements 01:40 Introduction
- Graciela Pineyro: Resilience, Lab Life, and the Zoom Effect | Dr. GPCR Ecosystem
forced — project planning in self-contained blocks, flatter meeting dynamics, planned reflection time — may taking "civically with responsibility and a grain of salt" — acknowledging that back-and-forth closures may forced by the shutdown — planned reflection, remote meeting inclusion, block-based project design — may
- Gunnar Schulte: Frizzled Receptors and the GPCR Identity Question | Dr. GPCR Ecosystem
are being used to argue for GPCR-like activation in frizzled Pathway selectivity — how the receptor may The Wnt ligand problem may be the field's deepest bottleneck Wnt ligands are approximately 35–40 kDa, Disheveled may regulate access to both G-protein and beta-catenin pathways through conformational selection Episode Timeline Timestamps are AI-generated from the transcript and may not reflect the final edited
- Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem
May 28, 2026. . < Back to Webinars 📅 Thursday, May 28, 2026 at 3:00:00 PM UTC 🤝 Webinar in collaboration with: Eurofins





















